- Report
- February 2023
- 190 Pages
Sweden
From €2433EUR$2,490USD£2,031GBP
- Report
- January 2023
- 190 Pages
United Kingdom
From €2433EUR$2,490USD£2,031GBP
- Report
- January 2023
- 125 Pages
United States
From €2433EUR$2,490USD£2,031GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2433EUR$2,490USD£2,031GBP
- Report
- January 2023
- 127 Pages
Global
From €2198EUR$2,250USD£1,835GBP
- Drug Pipelines
- February 2019
- 43 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Drug Pipelines
- February 2018
- 33 Pages
Global
From €9771EUR$10,000USD£8,157GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3517EUR$3,600USD£2,936GBP
- Report
- November 2023
- 130 Pages
Global
From €1905EUR$1,950USD£1,591GBP
- Report
- November 2024
- 70 Pages
Australia
From €2433EUR$2,490USD£2,031GBP
- Report
- March 2023
- 130 Pages
Japan
From €2433EUR$2,490USD£2,031GBP
- Report
- March 2023
- 190 Pages
Germany
From €2433EUR$2,490USD£2,031GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2433EUR$2,490USD£2,031GBP
- Report
- February 2023
- 130 Pages
France
From €2433EUR$2,490USD£2,031GBP
- Report
- February 2023
- 130 Pages
Canada
From €2433EUR$2,490USD£2,031GBP
- Report
- February 2023
- 120 Pages
Israel
From €2433EUR$2,490USD£2,031GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1944EUR$1,990USD£1,623GBP
- Report
- July 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
- Report
- June 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
- Report
- June 2021
- 50 Pages
China
From €2540EUR$2,600USD£2,121GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more